The disease-modifying therapy is approved to treat all indications covered by Tysabri

The decision follows a recent recommendation from the European Medicines Agency’s human medicines committee

Updated Date: Thu, 17 Aug 2023 00:00:00 EDT

Updated Date: Thu, 17 Aug 2023 00:00:00 EDT

bmj;382/aug24_12/p1958/FAF1fa“As sharp as a needle and as kind as a saint,” said Debo Mitford, Duchess of Devonshire, to […]

I’ll keep it brief NHS England has partnered with supermarket Morrisons to put cancer awareness messaging on underwear […]

The General Medical Council’s (GMC) updated guidance, Good Medical Practice, is a disappointing missed opportunity to embed sustainability […]

AbstractObjectiveTo determine the effects of salt reduction interventions designed for home cooks and family members.DesignCluster randomised controlled trial.SettingSix […]

We thank Bray for emphasising the fundamental role of psychological factors in chronic pain.12 The definition of pain […]

International donations cannot keep up with the pace of the growing health crisis in Afghanistan and if not […]